Apply Now for the Paul Silver Tribute Award!
Applications are now being accepted for the annual Paul Silver Tribute Award. The award is open to young people with Alport Syndrome, ages 16-22.
Alport Syndrome Research Studies
Regulus Therapeutics is recruiting for a Phase II study to evaluate a new investigational agent, RG-012, in people with Alport syndrome. In addition, Regulus is still conducting an observational study to learn more about how the disease progresses. For more details, including international participating study locations, go to the study website.
Research Funding Announcement
Announcing funding of two $100,000 Alport Syndrome research projects.
Support ASF While You Shop
Shop online at Amazon, Best Buy, Nike, and thousands of other stores and support ASF while you shop. Learn how!
Shop the ASF Store
Help raise awareness and show your support for Alport Syndrome patients and families with sweatshirts, t-shirts, mugs, key rings and other merchandise at the ASF Store.
Join the Patient Registry
Be advised of new clinical studies and trials. Join today!